Seven Corners Publishes CCUR Holdings Long Thesis--$7.47/Share Target Price (102% Potential Upside)
Please note that Seven Corners published its long investment thesis on CCUR Holdings (ticker CCUR) today, July 31, 2019, with the following high-level bullet points: Expected Value vs. $3.70 Market Price (as of 7/31/19) = $7.47/share 102% Upside To Our Price Target (Could Be Higher Pending Recent Repurchase Activity) Company Trades at Just 62% of Book Value Despite Potential for Significant Profitability To find a PDF containing our full CCUR writeup, please visit our Researc
Merrimack Pharmaceuticals - Long Thesis UPDATE
Approximately two weeks ago, Seven Corners published its long thesis on Merrimack Pharmaceuticals (MACK). [Please see our full writeup in our Research section here.] Since then several material events have transpired, giving a bit more clarity to the MACK investment thesis, as follows: $1.50 SPECIAL DIVIDEND ANNOUNCEMENT On July 25th the company announced that it will be returning half of its cash to shareholders in the form of a $20 million special dividend, equaling $1.50/s
Seven Corners Capital Scorecard: Results of Four Years of Public Picks
As an investor is only as good as his or her actual bottom-line results over time ("You are what your results say you are"), we herewith provide the aggregate results for the stock picks (longs, shorts and special situations) which we publicly posted on our Research page on this website during the 4-year period from July 1, 2015 through June 30, 2019. Please note: all stock prices (x) for open picks are as of July 17, 2019 and (y) for closed picks are as of the date of closur
